MetLife Investment Management LLC Has $529,000 Position in Proto Labs, Inc. $PRLB

MetLife Investment Management LLC reduced its stake in Proto Labs, Inc. (NYSE:PRLB) by 2.1% in the 1st quarter, according to the company in its most recent filing with the SEC. The fund owned 15,105 shares of the industrial products company’s stock after selling 330 shares during the quarter. MetLife Investment Management LLC owned approximately 0.06% of Proto Labs worth $529,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in the stock. Wellington Management Group LLP lifted its holdings in Proto Labs by 97.4% in the 1st quarter. Wellington Management Group LLP now owns 711,738 shares of the industrial products company’s stock worth $24,939,000 after purchasing an additional 351,097 shares during the last quarter. Algert Global LLC lifted its holdings in Proto Labs by 137.3% in the 1st quarter. Algert Global LLC now owns 85,084 shares of the industrial products company’s stock worth $2,981,000 after purchasing an additional 49,230 shares during the last quarter. American Century Companies Inc. lifted its holdings in Proto Labs by 38.8% in the 1st quarter. American Century Companies Inc. now owns 73,004 shares of the industrial products company’s stock worth $2,558,000 after purchasing an additional 20,425 shares during the last quarter. Russell Investments Group Ltd. lifted its holdings in Proto Labs by 91.8% in the 1st quarter. Russell Investments Group Ltd. now owns 38,679 shares of the industrial products company’s stock worth $1,355,000 after purchasing an additional 18,508 shares during the last quarter. Finally, Public Sector Pension Investment Board lifted its holdings in Proto Labs by 27.2% in the 1st quarter. Public Sector Pension Investment Board now owns 77,679 shares of the industrial products company’s stock worth $2,722,000 after purchasing an additional 16,598 shares during the last quarter. 84.54% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

Several research analysts have commented on PRLB shares. Craig Hallum raised Proto Labs from a “hold” rating to a “buy” rating and set a $54.00 price target on the stock in a research report on Friday, August 1st. Cantor Fitzgerald lifted their price target on Proto Labs from $50.00 to $51.00 and gave the stock an “overweight” rating in a research report on Friday, August 1st. Finally, Wall Street Zen raised Proto Labs from a “buy” rating to a “strong-buy” rating in a research report on Saturday, August 2nd. Two equities research analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the stock. According to MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus target price of $52.50.

Proto Labs Stock Down 0.5%

Shares of NYSE PRLB opened at $49.97 on Monday. The company has a market cap of $1.19 billion, a P/E ratio of 83.28 and a beta of 1.27. Proto Labs, Inc. has a 12 month low of $26.34 and a 12 month high of $51.09. The business’s 50 day moving average is $44.29 and its two-hundred day moving average is $39.68.

Proto Labs (NYSE:PRLB) last released its quarterly earnings data on Thursday, July 31st. The industrial products company reported $0.41 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.33 by $0.08. The business had revenue of $135.06 million for the quarter, compared to analysts’ expectations of $128.05 million. Proto Labs had a return on equity of 2.22% and a net margin of 2.91%.Proto Labs’s quarterly revenue was up 7.6% on a year-over-year basis. During the same period in the previous year, the business posted $0.38 earnings per share. Proto Labs has set its Q3 2025 guidance at 0.350-0.430 EPS. Sell-side analysts expect that Proto Labs, Inc. will post 0.81 earnings per share for the current fiscal year.

Insider Activity

In other news, CEO Suresh Krishna acquired 1,725 shares of the stock in a transaction dated Monday, August 4th. The shares were acquired at an average cost of $43.51 per share, for a total transaction of $75,054.75. Following the completion of the transaction, the chief executive officer owned 18,021 shares in the company, valued at approximately $784,093.71. This trade represents a 10.59% increase in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Corporate insiders own 1.20% of the company’s stock.

Proto Labs Company Profile

Proto Labs, Inc, together with its subsidiaries, operates as a digital manufacturer of custom parts in the United States and Europe. The company offers injection molding; computer numerical control machining; three-dimensional printing; and sheet metal fabrication products. It serves developers and engineers, who use 3D computer-aided design software to design products across a range of end-markets.